BREAST CARCINOMA

This study tested a new drug called NUV-868, alone or with other cancer drugs (olaparib or enzalutamide), in 82 adults with advanced solid tumors like ovarian, pancreatic, prostate, or breast cancer. The main goals were to check safety and find the right dose. The trial was stopp…

This study tested whether combining metformin (a diabetes drug) with doxycycline (an antibiotic) could help treat localized breast or uterine cancer. It involved 29 adults who were scheduled for surgery. The goal was to see if the drugs could change certain markers in the tumor's…

This study tested whether a tamoxifen gel applied to the skin could work as well as the pill form to lower breast cancer risk in women with certain high-risk breast conditions. About 65 women with atypical hyperplasia or lobular carcinoma in situ were planned to take part. The tr…

This study looked at whether adding a genetic risk score to standard breast cancer risk tools helps African American and Hispanic women decide on extra screening or prevention. About 19 women took part. The goal was to see if personalized genetic information improves understandin…

This study explored new ways to measure and manage pain in cancer patients and survivors. Researchers used a non-invasive brain imaging technique (fNIRS) to see how the brain reacts to pain and tested whether virtual reality (VR) could help reduce pain and the need for pain medic…